GlassScriptPhysician profile
Rodrigo Erana
NPI 1033290077
$835.30
in general payments reported to CMS, 2019-2025
12 companies · $96.89 in 2025
The $96.89 reported for 2025 was less than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2021: $49.54 · 2022: $70.27 · 2023: $361 · 2024: $31.64 · 2025: $96.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $489.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Servier Pharmaceuticals LLC | $167.78 | 2019-2025 | |
| Fennec Pharmaceuticals, INC. | $142.30 | 2023 | Pedmark |
| Genzyme Corporation | $125.00 | 2023 | |
| Novartis Pharmaceuticals Corporation | $117.20 | 2019-2023 | |
| Pfizer INC. | $81.44 | 2022-2025 | |
| Pharming Healthcare, INC. | $62.55 | 2023-2025 | Ruconest |
| Csl Behring | $35.57 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.55 | 2025 | Advate |
| Y-Mabs Therapeutics, INC. | $24.93 | 2023 | Danyelza |
| Bayer Healthcare Pharmaceuticals INC. | $18.39 | 2022 | |
| Agios Pharmaceuticals, INC. | $17.62 | 2024 | |
| Azurity Pharmaceuticals, INC. | $13.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodrigo Erana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.